Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Nautilus Biotechnology, Inc. | exhibit322.htm |
| EX-31.2 - EX-31.2 - Nautilus Biotechnology, Inc. | exhibit312.htm |
| EX-31.1 - EX-31.1 - Nautilus Biotechnology, Inc. | exhibit311.htm |
| 10-Q - 10-Q - Nautilus Biotechnology, Inc. | naut-20210630.htm |
Exhibit 32.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Nautilus Biotechnology, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Sujal Patel, hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: August 10, 2021 | By: | /s/ Sujal Patel | ||||||
| Sujal Patel | ||||||||
President and Chief Executive Officer | ||||||||
(Principal Executive Officer) | ||||||||